Clear Harbor Asset Management Lifted General Mtrs Co (GM) Stake By $4.86 Million, Pieris Pharmaceuticals (PIRS) Had 4 Analysts Last Week

Clear Harbor Asset Management Llc increased General Mtrs Co (GM) stake by 83.95% reported in 2016Q4 SEC filing. Clear Harbor Asset Management Llc acquired 142,845 shares as General Mtrs Co (GM)’s stock rose 8.74%. The Clear Harbor Asset Management Llc holds 313,005 shares with $10.91M value, up from 170,160 last quarter. General Mtrs Co now has $52.04B valuation. The stock increased 0.03% or $0.01 on April 28, reaching $34.64. About 786 shares traded. General Motors Company (NYSE:GM) has risen 6.95% since September 22, 2016 and is uptrending. It has underperformed by 2.56% the S&P500.

Among 4 analysts covering Pieris Pharmaceuticals (NASDAQ:PIRS), 4 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Pieris Pharmaceuticals had 7 analyst reports since July 22, 2015 according to SRatingsIntel. The stock of Pieris Pharmaceuticals Inc (NASDAQ:PIRS) has “Buy” rating given on Wednesday, July 22 by TH Capital. The firm earned “Buy” rating on Wednesday, July 22 by Roth Capital. The rating was maintained by JMP Securities with “Market Outperform” on Wednesday, March 9. Roth Capital reinitiated the stock with “Buy” rating in Friday, August 5 report. JMP Securities initiated the stock with “Market Outperform” rating in Wednesday, August 12 report. The firm has “Outperform” rating by Oppenheimer given on Tuesday, July 28. The stock has “Buy” rating by Roth Capital on Thursday, August 13. See Pieris Pharmaceuticals Inc (NASDAQ:PIRS) latest ratings:

Pieris Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. The company has market cap of $106.42 million. The Company’s pipeline includes immuno-oncology multi-specifics tailored for the tumor micro-environment, an inhaled Anticalin to treat uncontrolled asthma and a half-life-optimized Anticalin to treat anemia. It currently has negative earnings. The Company’s Anticalins proteins are a class of low molecular-weight therapeutic proteins derived from lipocalins, which are naturally occurring low-molecular weight human proteins typically found in blood plasma and other bodily fluids.

It closed at $2.41 lastly. It is down 44.31% since September 22, 2016 and is uptrending. It has outperformed by 34.80% the S&P500.

Investors sentiment decreased to 1.08 in 2016 Q4. Its down 0.06, from 1.14 in 2016Q3. It fall, as 73 investors sold GM shares while 302 reduced holdings. 128 funds opened positions while 277 raised stakes. 1.06 billion shares or 1.29% more from 1.05 billion shares in 2016Q3 were reported. New Mexico Educational Retirement Board, New Mexico-based fund reported 151,900 shares. Invesco Limited has invested 0.26% in General Motors Company (NYSE:GM). Foundry Limited Liability has invested 0.55% in General Motors Company (NYSE:GM). Daiwa Sb Invs accumulated 6,070 shares. Krasney Financial Lc reported 189,835 shares. The Illinois-based Driehaus Cap Mngmt Ltd Co has invested 0.65% in General Motors Company (NYSE:GM). Arrowpoint Asset Ltd Co owns 250,230 shares for 0.14% of their portfolio. California State Teachers Retirement Systems owns 3.01 million shares for 0.21% of their portfolio. 93,871 were reported by Clinton Grp Incorporated Inc. Renaissance Tech Ltd Liability Corporation has invested 0.04% in General Motors Company (NYSE:GM). Natl Asset Mngmt Incorporated reported 13,668 shares or 0.1% of all its holdings. Northern accumulated 14.96M shares. Blackrock Advsr Lc invested 0.02% in General Motors Company (NYSE:GM). Jpmorgan Chase reported 34.73M shares stake. Mitsubishi Ufj Bk Corporation owns 3.16M shares or 0.23% of their US portfolio.

Among 21 analysts covering General Motors Company (NYSE:GM), 10 have Buy rating, 2 Sell and 9 Hold. Therefore 48% are positive. General Motors Company had 43 analyst reports since July 24, 2015 according to SRatingsIntel. The firm has “Strong-Buy” rating given on Friday, March 31 by Tigress Financial. Morgan Stanley initiated the shares of GM in report on Wednesday, February 24 with “Underweight” rating. The stock has “Sector Perform” rating by RBC Capital Markets on Friday, July 22. Morgan Stanley reinitiated the stock with “Underweight” rating in Monday, August 24 report. The stock of General Motors Company (NYSE:GM) earned “Hold” rating by Deutsche Bank on Wednesday, October 14. RBC Capital Markets maintained the stock with “Sector Perform” rating in Friday, July 24 report. RBC Capital Markets maintained the shares of GM in report on Thursday, October 22 with “Sector Perform” rating. Morgan Stanley upgraded General Motors Company (NYSE:GM) rating on Monday, September 19. Morgan Stanley has “Overweight” rating and $37 target. Credit Suisse upgraded General Motors Company (NYSE:GM) on Friday, July 24 to “Neutral” rating. Morgan Stanley upgraded it to “Equal-Weight” rating and $29 target in Friday, May 6 report.

Clear Harbor Asset Management Llc decreased Jpmorgan Chase & Co (NYSE:JPM) stake by 5,951 shares to 52,277 valued at $4.51M in 2016Q4. It also reduced Voya Finl Inc (NYSE:VOYA) stake by 142,580 shares and now owns 16,505 shares. Anthem Inc (NYSE:ANTM) was reduced too.